Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Fragaria pentaphylla genome sequencing

PROVIDER: PRJNA801713 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17815870_subreads.fastq.gz	Fastqsanger.gz
	SRR17815871_1.fastq.gz	Fastqsanger.gz
	SRR17815871_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 3 of 3

Similar Datasets

Project description:Fragaria pentaphylla RNA sequencing

| PRJNA804380 | ENA

Fragaria pentaphylla

Project description:Fragaria pentaphylla overview

| PRJNA428121 | ENA

Fragaria pentaphylla

Project description:Fragaria pentaphylla Raw sequence reads

| PRJNA952499 | ENA

Fragaria pentaphylla

Project description:Fragaria pentaphylla Raw sequence reads

| PRJNA953337 | ENA

Fragaria pentaphylla

Project description:Fragaria pentaphylla Raw sequence reads

| PRJNA645041 | ENA

Fragaria pentaphylla cultivar:Fragaria pentaphylla Lozinsk

Project description:RNA-Seq of Fragaria Pentaphylla Lozinsk

| PRJNA396890 | ENA

Glycosmis pentaphylla

Project description:Glycosmis pentaphylla Genome sequencing

| PRJNA782378 | ENA

Fragaria nilgerrensis and Fragaria pentaphylla

Project description:Integrated metabolomic and transcriptomic analyses reveal different anthocyanin biosynthetic pathways in Fragaria nilgerrensis and Fragaria pentaphylla

| PRJNA606938 | ENA

Project description:Genome-wide identification and analysis of anthocyanin synthesis-related R2R3-MYB genes in Fragaria pentaphylla

| PRJNA1125636 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data